Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma
Open Access
- 1 April 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (22) , 32156-32171
Abstract
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphomaKeywords
This publication has 49 references indexed in Scilit:
- MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 ( TNFAIP3, A20 )Proceedings of the National Academy of Sciences, 2012
- A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory diseaseProceedings of the National Academy of Sciences, 2011
- Age, gender, and racial differences in incidence and survival in primary CNS lymphomaBritish Journal of Cancer, 2011
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- Intracellular osteopontin (iOPN) and immunityImmunologic Research, 2010
- Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastomaImmunology, 2010
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- Differential gene expression in central nervous system lymphomaBlood, 2009
- B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathwaysMolecular Immunology, 2008
- Pathway analysis of primary central nervous system lymphomaBlood, 2008